Bond Screener
Amgen
LEI 62QBXGPJ34PQ72Z12S66, SWIFT AGGNUS62XXX
Organization name
Amgen, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
59,192 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
|
General information
-
Organization nameAmgen, Inc.
-
Organization statusOperating organization
-
AddressC/O Corporation Service Company 2711 Centerville Road Suite 400 Wilmington, USA, 19808
-
Site
-
IR Site
News
-
Amgen's Repatha Cuts Death Risk 20% In High-Risk Patients Without Prior Heart Attack Or Stroke31/08/2026
-
Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?29/08/2026
-
Here's Why Amgen (AMGN) is a Strong Momentum Stock21/08/2026
-
BMY or AMGN: Which Is the Better Value Stock Right Now?04/08/2026
-
Affiliated Managers Group (NYSE: AMG) Demonstrates Strong Financial Performance and Growth in Asset Management01/08/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameAmgen, Inc.
-
Organization statusOperating organization
-
AddressC/O Corporation Service Company 2711 Centerville Road Suite 400 Wilmington, USA, 19808
-
Site
-
IR Site
Codes
-
LEI62QBXGPJ34PQ72Z12S66
-
SWIFTAGGNUS62XXX
-
SIC2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
-
CIK0000318154
-
EIN95-3540776
